We are live on ! Find out more
TDOC icon

Teladoc Health

366 hedge funds and large institutions have $1.15B invested in Teladoc Health in 2024 Q3 according to their latest regulatory filings, with 54 funds opening new positions, 85 increasing their positions, 131 reducing their positions, and 96 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding in top 10

Funds holding in top 10: 1 → 2 (+1)

26% more call options, than puts

Call options by funds: $60.8M | Put options by funds: $48.2M

8.66% less ownership

Funds ownership: 81.94% → 73.28% (-8.7%)

10% less funds holding

Funds holding: 406 → 366 (-40)

35% less repeat investments, than reductions

Existing positions increased: 85 | Existing positions reduced: 131

37% less capital inflows, than outflows

Capital inflows: $219M | Capital outflows: $346M

44% less first-time investments, than exits

New positions opened: 54 | Existing positions closed: 96

Holders
366
Holders Change
-40
Holders Change %
-9.85%
% of All Funds
5.24%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.03%
New
54
Increased
85
Reduced
131
Closed
96
Calls
$60.8​M
Puts
$48.2​M
Net Calls
+$12.6​M
Net Calls Change
+$14.8​M

TDOC Hedge Fund Activity: Q3 2024 in Review

366 of the 6,990 institutional investors tracked by Wall St. Rank reported a position in Teladoc Health (TDOC) for Q3 2024, worth a combined $1.15B — down 15% from $1.36B a quarter earlier.

Sellers outnumbered buyers: 96 funds closed out of TDOC and 54 opened new positions — a net loss of 42 holders — while 131 trimmed existing stakes and 85 added.

The largest buyer was Goldman Sachs, adding an estimated $45M. The largest seller was ARK Investment Management, exiting entirely with an estimated $61.9M sold.

  • 366 institutional investors held Teladoc Health (TDOC) as of Q3 2024, down from 406 in Q2 2024.
  • Funds reported $1.15B of Teladoc Health stock for Q3 2024, down 15% quarter-over-quarter.
  • 54 funds opened new Teladoc Health positions in Q3 2024 and 96 closed out, a net change of -42 holders.
  • The largest Teladoc Health buyer in Q3 2024 was Goldman Sachs, an estimated $45M added.
  • The largest Teladoc Health seller in Q3 2024 was ARK Investment Management, an estimated $61.9M sold.

Based on aggregated 13F filings for Q3 2024.